Predictive Role of the Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib

DOI QR Code

Tanoglu, Alpaslan (Department of Gastroenterology, GATA Haydarpasa Training Hospital) ;
Karagoz, Ergenekon (Department of Infectious Diseases and Clinical, GATA Haydarpasa Training Hospital)

Balta S, Cakar M, Demirkol S, Arslan Z, Akhan M (2013). Higher neutrophil to lymhocyte ratio in patients with metabolic syndrome. Clin Appl Thromb Hemost, 19, 579. https://doi.org/10.1177/1076029612475023
Song T, Zhang W, Wu Q, Kong D, Ma W (2011). A single center experience of sorafenib in advanced hepatocellular carcinoma patients: evaluation of prognostic factors. Eur J Gastroenterol Hepatol, 23, 1233-8. https://doi.org/10.1097/MEG.0b013e32834bd2d0
Stotz M, Gerger A, Eisner F, et al (2013). Increased neutrophillymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer, 109, 416-21. https://doi.org/10.1038/bjc.2013.332
Karaman M, Balta S, Ay SA, et al (2013). The comparative effects of valsartan and amlodipine on vWf Levels and N/L ratio in patients with newly diagnosed hypertension. Clin Exp Hypertens, 35, 516-22. https://doi.org/10.3109/10641963.2012.758734
Mulcahy MF (2005). Management of hepatocellular cancer. Curr Treat Options Oncol, 6, 423-35. https://doi.org/10.1007/s11864-005-0045-7
Qin LX, Tang ZY (2002). The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J Gastroenterol, 8, 193-9.
Zheng YB, Zhao W, Liu B, et al (2013). The blood neutrophil-tolymphocyte ratio predicts survival in patients with advanced hepatocellular carcinoma receiving sorafenib. Asian Pac J Cancer Prev, 14, 5527-31. https://doi.org/10.7314/APJCP.2013.14.9.5527

Is the Combination of Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios a Useful Predictor of Treatment Response and Prognosis in Patients with Non-Small Cell Lung Cancer? vol.15, pp.10, 2014, https://doi.org/10.7314/APJCP.2014.15.10.4373
Predictive role of neutrophil to lymphocyte ratio in Henoch–Schonlein purpura related gastrointestinal bleeding vol.34, pp.9, 2014, https://doi.org/10.1007/s00296-014-3028-9
Assessment of clinical and radiological response to sorafenib in hepatocellular carcinoma patients vol.7, pp.1, 2015, https://doi.org/10.4254/wjh.v7.i1.33
Neutrophil-to-lymphocyte ratio: a biomarker for predicting systemic involvement in adult IgA vasculitis patients vol.31, pp.6, 2017, https://doi.org/10.1111/jdv.14176